Beta Drugs Limited reported strong growth in revenue, EBITDA, and PAT for H125 along with successful completion of the ZAZIBONA audit, highlighting a 30% year-on-year growth in PAT and a total revenue of Rs 180.3 Cr.
AI Assistant
Beta Drugs Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.